SRTA Chief Accounting Officer awarded 11,844 vested RSUs tied to sale

Rhea-AI Filing Summary

Amir Cohen, Chief Accounting Officer and director of Strata Critical Medical, Inc. (SRTA), reported a grant of 11,844 fully vested restricted stock units (RSUs) on 08/29/2025. The RSUs vest and will be settled in shares of the issuer's Class A common stock at no cash price ($0). Following this transaction, Mr. Cohen beneficially owns 103,760 shares. The RSU grant is effective upon completion of the issuer's previously disclosed sale of its Passenger business to Joby Aero, Inc. under an Equity Purchase Agreement dated August 1, 2025. The Form 4 was signed by attorney-in-fact Melissa M. Tomkiel on 09/03/2025.

Positive

• Increased insider ownership: Reporting person’s beneficial ownership rises to 103,760 shares
• Fully vested grant: The 11,844 RSUs are fully vested and will be settled in common stock
• Transaction tied to strategic sale: RSUs are effective upon completion of sale of Passenger business to Joby Aero, Inc.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Insider received fully vested RSUs tied to a divestiture, increasing direct ownership without cash outlay.

The reported grant of 11,844 fully vested RSUs to the Chief Accounting Officer is explicitly linked to the closing of a strategic divestiture of the Passenger business to Joby Aero, Inc. Fully vested RSUs settled in common stock represent immediate equity transfer and increase the reporting person's beneficial ownership to 103,760 shares. This is a compensatory/transaction-linked grant rather than a market purchase and may reflect post-transaction compensation or retention alignment with the company's new structure.

Securities Analyst

TL;DR: Insider ownership increased through vested RSUs; transaction is non-cash and contingent on a specified sale closing.

The Form 4 discloses a non-cash acquisition of equity (11,844 RSUs) at $0 price, effective upon completion of the specified sale. The filing shows a concrete change in beneficial ownership and clarifies settlement in common stock. As reported, this is a post-transaction equity grant rather than an open-market trade, so it does not signal buying or selling intent but does increase insider alignment with shareholders numerically.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cohen Amir

(Last) (First) (Middle)

C/O STRATA CRITICAL MEDICAL, INC.

31 HUDSON YARDS, 14TH FLOOR

(Street)

NEW YORK NY 10001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock, $0.0001 par value per share	08/29/2025		A		11,844(1)	A	$0	103,760	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of fully vested Restricted Stock Units ("RSUs") effective upon the completion of the Issuer's previously announced sale of its Passenger business to Joby Aero, Inc. pursuant to that certain Equity Purchase Agreement, dated as of August 1, 2025. The RSUs will be settled in shares of the Issuer's common stock.

Remarks:

	/s/ Melissa M. Tomkiel, Attorney-in-fact for Amir Cohen	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Amir Cohen (SRTA) report on Form 4?

He reported a grant of 11,844 fully vested RSUs on 08/29/2025, settled in Class A common stock at $0.

How many shares does Amir Cohen beneficially own after the transaction?

Following the reported transaction he beneficially owns 103,760 shares.

Why were the RSUs granted to Amir Cohen?

The RSU grant is effective upon completion of the issuer's sale of its Passenger business to Joby Aero, Inc., per the Equity Purchase Agreement dated August 1, 2025.

Was this a market purchase or a compensatory grant?

The filing describes a grant of fully vested RSUs to be settled in common stock, indicating a non-market, compensatory/transaction-linked grant.

Who signed the Form 4 and when?

The Form 4 was signed by attorney-in-fact Melissa M. Tomkiel on 09/03/2025.